Trial intelligence / Profile preview

Nebulised Dexmedetomidine vs Midazolam for Preoperative Anxiety and Emergence Delirium in Children

NCT05872087Phase 1Completed

Sponsor
Ain Shams University
Start
Nov 2022
Primary completion
Sep 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial of dexmedetomidine in preoperative anxiety and emergence delirium (ED) (2 arms), sponsored by Ain Shams University. Primary endpoints: Level of preoperative anxiety and Incidence of emergence delirium. Started Nov 2022; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

preoperative anxietyemergence delirium (ED)

Beyond the preview

Go deeper on NCT05872087.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05872087.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call